deferiprone has been researched along with Leucocythaemia in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guillon, J | 1 |
| Mamani-Matsuda, M | 1 |
| Massip, S | 1 |
| Leger, JM | 1 |
| Thiolat, D | 1 |
| Mossalayi, D | 1 |
| Jarry, C | 1 |
1 other study available for deferiprone and Leucocythaemia
| Article | Year |
|---|---|
Anti-leukemia activity of 7-hydroxy-2-substituted-methyl-5H-oxazolo[3,2-a]pyrimidin-5-one derivatives.
Topics: Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Deferiprone; Drug Screening Assays, | 2002 |